Insider · CIK 0001562371

Barry Richard

Reports to the SEC for 4 companies · AUSTIN, TX

sec.gov

Transactions

Companies

Filings

CIK

0001562371

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-30	FLNAFILANA THERAPEUTICS, INC.P Purchase	Director, President & CEO	PPurchase	+100K sh	$0.92	+$92K	1,337,964
2026-09-29	FLNAFILANA THERAPEUTICS, INC.P Purchase	Director, President & CEO	PPurchase	+207K sh	$0.90	+$186K	1,237,964
2026-09-28	FLNAFILANA THERAPEUTICS, INC.P Purchase	Director, President & CEO	PPurchase	+93.1K sh	$0.84	+$78.2K	1,031,151
2026-06-04	SRPTSarepta Therapeutics, Inc.A Award	Director	AAward	+16.9K sh	—	—	2,983,542
2025-11-20	FLNAFILANA THERAPEUTICS, INC.P Purchase	Director, President & CEO	PPurchase	+150K sh	$2.76	+$414K	938,060
2025-11-19	FLNAFILANA THERAPEUTICS, INC.P Purchase	Director, President & CEO	PPurchase	+73.4K sh	$2.75	+$202K	788,060
2025-09-22	FLNAFILANA THERAPEUTICS, INC.P Purchase	Director, President & CEO	PPurchase	+7,172 sh	$2.28	+$16.4K	714,675
2025-09-19	FLNAFILANA THERAPEUTICS, INC.P Purchase	Director, President & CEO	PPurchase	+400 sh	$2.25	+$900	660,595
2025-09-19	FLNAFILANA THERAPEUTICS, INC.P Purchase	Director, President & CEO	PPurchase	+46.9K sh	$2.29	+$107K	707,503
2025-09-18	FLNAFILANA THERAPEUTICS, INC.P Purchase	Director, President & CEO	PPurchase	+185K sh	$2.24	+$415K	660,195
2025-09-18	FLNAFILANA THERAPEUTICS, INC.P Purchase	Director, President & CEO	PPurchase	+5,400 sh	$2.13	+$11.5K	474,962
2025-05-16	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+12.4K sh	$32.63	+$403K	2,966,667
2025-05-16	SRPTSarepta Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−12.4K sh	—	—	0
2025-05-13	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10.5K sh	$13.71	+$144K	2,954,317
2025-05-13	SRPTSarepta Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10.5K sh	—	—	0
2025-05-13	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+9,746 sh	$25.18	+$245K	2,943,817
2025-05-13	SRPTSarepta Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,746 sh	—	—	0
2025-04-17	FLNAFILANA THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+350K sh	—	—	350,000
2025-03-10	SRPTSarepta Therapeutics, Inc. · Stock Options (right to buy)A Award	Director	AAward	+4,792 sh	—	—	4,792
2025-03-10	SRPTSarepta Therapeutics, Inc.A Award	Director	AAward	+2,383 sh	—	—	2,934,071
2024-10-01	FLNAFILANA THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+600K sh	—	—	600,000
2024-05-09	FLNAFILANA THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+15K sh	—	—	15,000
2024-04-23	FLNAFILANA THERAPEUTICS, INC.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+176K sh	$22.00	+$3.87M	469,562
2024-04-23	FLNAFILANA THERAPEUTICS, INC. · Common Stock WarrantM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−117K sh	—	—	0
2024-03-01	SRPTSarepta Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+3,679 sh	—	—	3,679
2024-03-01	SRPTSarepta Therapeutics, Inc.A Award	Director	AAward	+1,846 sh	—	—	2,931,688
2024-01-03	FLNAFILANA THERAPEUTICS, INC. · Common Stock WarrantA Award	Director, President & CEO	AAward	+117K sh	—	—	176,085
2023-11-03	SRPTSarepta Therapeutics, Inc.P Purchase	Director	PPurchase	+10K sh	$78.81	+$788K	10,000
2023-11-03	SRPTSarepta Therapeutics, Inc.P Purchase	Director	PPurchase	+40K sh	$78.81	+$3.15M	140,000
2023-08-22	FLNAFILANA THERAPEUTICS, INC.P Purchase	Director, President & CEO	PPurchase	+16.6K sh	$16.65	+$276K	293,477
2023-08-21	FLNAFILANA THERAPEUTICS, INC.P Purchase	Director, President & CEO	PPurchase	+1,906 sh	$16.80	+$32K	276,906
2023-05-04	FLNAFILANA THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+5,000 sh	$22.34	+$112K	5,000
2023-05-04	FLNAFILANA THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+20K sh	$22.34	+$447K	25,000
2023-03-07	FLNAFILANA THERAPEUTICS, INC.P Purchase	Director, President & CEO	PPurchase	+77.3K sh	$25.76	+$1.99M	275,000
2023-03-06	SRPTSarepta Therapeutics, Inc.A Award	Director	AAward	+1,523 sh	—	—	2,929,842
2023-03-06	SRPTSarepta Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+3,257 sh	—	—	3,257
2023-03-06	FLNAFILANA THERAPEUTICS, INC.P Purchase	Director, President & CEO	PPurchase	+11.6K sh	$26.13	+$302K	197,724
2022-08-23	FLNAFILANA THERAPEUTICS, INC.P Purchase	Director, President & CEO	PPurchase	+36.2K sh	$23.79	+$860K	186,159
2022-03-07	SRPTSarepta Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,077 sh	—	—	5,077
2022-03-07	SRPTSarepta Therapeutics, Inc.A Award	Director	AAward	+2,953 sh	—	—	2,928,319
2021-03-03	SRPTSarepta Therapeutics, Inc.A Award	Director	AAward	+2,726 sh	—	—	3,125,366
2021-03-03	SRPTSarepta Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,518 sh	—	—	5,518
2020-08-10	SRPTSarepta Therapeutics, Inc.G Gift	Director	GGift	−6,500 sh	—	—	3,122,640
2020-08-07	SRPTSarepta Therapeutics, Inc.S Sale	Director	SSale	−3,140 sh	$159.09	−$500K	3,129,140
2020-08-07	SRPTSarepta Therapeutics, Inc.S Sale	Director	SSale	−26.9K sh	$158.43	−$4.26M	3,132,280
2020-08-05	MDXGMIMEDX GROUP, INC.A Award	Director	AAward	+38.1K sh	—	—	3,338,135
2020-05-15	SRPTSarepta Therapeutics, Inc.S Sale	Director	SSale	−4,673 sh	$142.05	−$664K	3,159,140
2020-05-15	SRPTSarepta Therapeutics, Inc.S Sale	Director	SSale	−25.3K sh	$141.12	−$3.57M	3,163,813
2020-02-28	SRPTSarepta Therapeutics, Inc.A Award	Director	AAward	+2,075 sh	—	—	3,189,140
2020-02-28	SRPTSarepta Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+3,685 sh	—	—	3,685

Recent filings

Accepted (ET)
Oct 14
Barry Richard0001437749-26-031654
SEC(opens sec.gov)
Sep 304
Barry Richard0001437749-26-031597
SEC(opens sec.gov)
Jun 54
Barry Richard0001193125-26-260245
SEC(opens sec.gov)
Nov 244
Barry Richard0001437749-25-036125
SEC(opens sec.gov)
Nov 204
Barry Richard0001437749-25-035882
SEC(opens sec.gov)
Sep 234
Barry Richard0001437749-25-029725
SEC(opens sec.gov)
Sep 224
Barry Richard0001437749-25-029586
SEC(opens sec.gov)
May 194
Barry Richard0000950170-25-073954
SEC(opens sec.gov)
May 154
Barry Richard0000950170-25-071961
SEC(opens sec.gov)
Apr 214
Barry Richard0001437749-25-012554
SEC(opens sec.gov)
Mar 114
Barry Richard0000950170-25-037514
SEC(opens sec.gov)

Companies

Address

6801 N CAPITAL OF TEXAS HWY, BLDG 1 SUITE 300

AUSTIN, TX, 78731